PlainRecalls
FDA Drug Critical Class I Terminated

Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10

Reported: November 2, 2022 Initiated: September 29, 2022 #D-0019-2023

Product Description

Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10

Reason for Recall

Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets

Details

Units Affected
2,584 Bottles
Distribution
USA Nationwide
Location
Camarillo, CA

Frequently Asked Questions

What product was recalled?
Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10. Recalled by Golden State Medical Supply Inc.. Units affected: 2,584 Bottles.
Why was this product recalled?
Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
Which agency issued this recall?
This recall was issued by the FDA Drug on November 2, 2022. Severity: Critical. Recall number: D-0019-2023.